Leukaemia Care
9 FOLLOWERS
Leukaemia Care is a national blood cancer support charity. We are dedicated to ensuring that anyone affected by blood cancer receives the right information, advice and support. We not only support patients but carers and families too who can often carry a lot of the emotional strain when someone they love is diagnosed with blood cancer. Catch up with our latest news, current campaigns and appeals.
Leukaemia Care
4d ago
CAR-T therapy, tisagenlecleucel, has been given long term approval to be used on the NHS in England, thanks to a decision made by the National Institute for Health and Care Excellence's (NICE ..read more
Leukaemia Care
1M ago
Leukaemia Care are pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patient with an IDH1 mutation who are ineligible for standard induction chemotherapy now have access to ivosidenib with azacitidine thanks to the decision made by the Scottish Medicines Consortium (SMC) today ..read more
Leukaemia Care
1M ago
The Board of Trustees for Leukaemia Care is pleased to announce the appointment of Colin Dyer as the new Chief Executive of Leukaemia Care ..read more
Leukaemia Care
2M ago
We are pleased to report that higher risk myelofibrosis patients affected by enlarged spleen and/or anaemia to have access to momelotinib thanks to a decision made by the National Institute for Health and Care Excellence's (NICE) today ..read more
Leukaemia Care
2M ago
After thorough consideration and evaluation, we want to inform you that Leukaemia Care's HealthUnlocked Online Forum Service will be closing on the 30th April 2024 ..read more
Leukaemia Care
6M ago
The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have announced the approval of zanubrutinib on the NHS for patients with chronic lymphocytic leukaemia (CLL) in all nations of the UK ..read more
Leukaemia Care
6M ago
Today, the Scottish Medicines Consortium (SMC) has approved CAR-T therapy on the NHS in Scotland for all suitable adults over 25 with acute lymphoblastic leukaemia (ALL ..read more
Leukaemia Care
6M ago
Today, the Scottish Medicines Consortium (SMC) has announced the approval of maribavir (Livtencity), a new medicine for adults with a post-transplant CMV infection that is resistant to current treatments ..read more
Leukaemia Care
7M ago
Chief Executive, Zack Pemberton-Whiteley, will be leaving Leukaemia Care ..read more
Leukaemia Care
7M ago
Today, the Scottish Medicines Consortium (SMC) has announced the approval of ibrutinib in combination with venetoclax on the NHS in Scotland for patients with chronic lymphocytic leukaemia (CLL ..read more